Efficacy of an AS03 A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs
Auteur
De Vleeschauwer, A. R.; Baras, B.; Kyriakis, C. S.; Jacob, V.; Planty, C.; Giannini, S. L.; Mossman, S.; Van Reeth, K.Date
2012Sujet
Résumé
We used the pig model of influenza to examine the efficacy of an AS03 A-adjuvanted split H5N1 (A/Indonesia/05/2005) vaccine against challenge with a low pathogenic (LP) H5N1 avian influenza (AI) virus (duck/Minnesota/1525/1981) with only 85% amino acid homology in its HA1. Influenza seronegative pigs were vaccinated twice intramuscularly with adjuvanted vaccine at 3 antigen doses, unadjuvanted vaccine or placebo. All pigs were challenged 4 weeks after the second vaccination and euthanized 2 days later. After 2 vaccinations, all pigs in the adjuvanted vaccine groups had high hemagglutination inhibiting (HI) antibody titers to the vaccine strain (160-640), and lower antibody titers to the A/Vietnam/1194/04 H5N1 strain and to 2 LP H5 viruses with 90-91% amino acid homology to the vaccine strain (20-160). Eight out of 12 pigs had HI titers (10-20) to the challenge virus immediately before challenge. Neuraminidase inhibiting antibodies to the challenge virus were detected in most pigs (7/12) and virus neutralizing antibodies in all pigs. There was no antigen-dose dependent effect on the antibody response among the pigs immunized with adjuvanted H5N1 vaccines. After challenge, these pigs showed a complete clinical protection, reduced lung lesions and a significant protection against virus replication in the respiratory tract. Though the challenge virus showed only moderate replication efficiency in pigs, our study suggests that AS03 A-adjuvanted H5N1 vaccine may confer a broader protection than generally assumed. The pros and cons of the pig as an H5N1 challenge model are also discussed. © 2012 Elsevier Ltd.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Serological Evidence of Pandemic H1N1 Influenza Virus Infections in Greek Swine
Kyriakis C.S., Papatsiros V.G., Athanasiou L.V., Valiakos G., Brown I.H., Simon G., Van Reeth K., Tsiodras S., Spyrou V., Billinis C. (2016)The introduction of the 2009 pandemic H1N1 (pH1N1) influenza virus in pigs changed the epidemiology of influenza A viruses (IAVs) in swine in Europe and the rest of the world. Previously, three IAV subtypes were found in ... -
Field evaluation of a live vaccine against porcine reproductive and respiratory syndrome in fattening pigs
Mavromatis, I.; Kritas, S. K.; Alexopoulos, C.; Tsinas, A.; Kyriakis, S. C. (1999)A live vaccine based on a European isolate of porcine reproductive and respiratory syndrome virus (Porcilis PRRS) was tested in this study in order to determine the protection of fattening pigs against the respiratory form ... -
Influenza virus genotypes circulating in central greece during 2012-2014 and vaccine strain match
Plakokefalos E., Vontas A., Florou Z., Valiakos G., Georgantza K., Sarrou S., Labronikou M., Gramoustianou E., Peteinaki E., Markoulatos P., Minas A., Krikelis V., Noulas A., Manouras A. (2015)During the period 2012-2014 in central Greece, influenza A(H1N1), A(H3N2) and B virus genotypes were detected and isolated from individuals with influenza illness. Influenza A(H1N1) and A (H3N2) viruses were the dominant ...